National HealthCare Corporation (NHC) fair value

ACCE thesis

National HealthCare Corporation operates skilled nursing facilities, assisted living communities and home health and hospice agencies, with its revenue concentrated in Medicare and Medicaid reimbursement for post-acute and long-term care. The business has a structural tailwind in an aging US population, and its scale across a large owned and leased facility base gives it bargaining weight with payers and staffing agencies that smaller operators lack. Revenue growth of 8.8% and a 12.0% operating margin are solid for a sector where margins are usually thin, and a 13.3% ROE supports the quality read. The gap between a trailing P/E of 27.6 and a forward P/E of 9.9 is the number to examine: it implies the market is either pricing in earnings that are not yet in the trailing figures or doubting that the forward estimates hold, and that spread is the core question for a deeper look. With no index membership, the stock sits outside the passive flows that often support mid-cap healthcare names, which makes its valuation more dependent on fundamental work than on positioning.